Conclusion:In this real-world study, low-to medium-dose of telitacicept combined with conventional therapy showed good onset efficacy and safety for treating IgA patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jumpei Hosotani
Mikiko Shibata
Daisuke Yamazaki
Kidney International Reports
Tokyo Metropolitan University
Osaka City General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Hosotani et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69c770418bbfbc51511e0835 — DOI: https://doi.org/10.1016/j.ekir.2026.106227